Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, Growing at a CAGR of 20.00% From 2024-2032.Mexico, Mexico City, Nov. 07, ...
BEAM-101 is an investigational treatment for SCD that uses a form of gene editing known as base editing to modify the promotor regions of the HBG1/2 genes, enabling BCL11A genes to produce fetal ...
Recruitment for a Type 2 diabetes study in youth at the University of Oklahoma College of Medicine is underway, according to a release. The National Institute of Diabetes and Digestive and Kidney ...
Hamas is an Islamist militant movement that has controlled the Gaza Strip for nearly two decades. It violently rejects the existence of Israel, which it claims is occupying Palestine. In October ...